Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $31.27M.
ENTERPRISE VALUE (EV)
$31.27M
Foghorn Therapeutics Inc.
Market Cap
$112.14M
Enterprise Value (EV)
$31.27M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Foghorn Therapeutics Inc. (FHTX) | $112.14M | $31.27M |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.33M | $38.16M |
| Immunic, Inc. (IMUX)vs › | $110.88M | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.42M | $105.93M |
| Apyx Medical Corporation (APYX)vs › | $109.49M | $121.50M |
| Coya Therapeutics, Inc. (COYA)vs › | $115.06M | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.59M | $106.36M |
| BGM Group Ltd. (BGM)vs › | $107.84M | $97.50M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.95M | $92.87M |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.38M | $107.23M |
Market Cap
$112.14M
Total Debt
$0.00
Cash
$80.88M
Enterprise Value
$31.27M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
